Search Results 621-630 of 37957 for Two-phase

  1. Detection of esophageal cancer via assay of novel methylated DNA markers in plasma - Mayo Clinic

    The two main subtypes of esophageal cancer, esophageal adenocarcinoma (EAC) ... To overcome this, we are recruiting and enrolling patients into a phase two ...

  2. Prostate cancer - Diagnosis and treatment - Mayo Clinic

    Grade group 2. This means the Gleason score is 7. The most common grade in the prostate biopsy samples is 3. The second grade is 4. Grade group 3 ...

  3. A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer - Mayo Clinic

    This is a Phase 2, open-label, 2-part, multicenter study in subjects with MSS relapsed/refractory colorectal cancer. The primary objective of Part 1 is to ...

  4. VG161 in the Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma - Mayo Clinic

    Overview. Tab Title Description. Study typeInterventional Study phase2. Study ... unresectable HCC, with documented disease progression after at least two lines ...

  5. Infant development: Milestones from 4 to 6 months - Mayo Clinic

    To help your baby focus, put out only one or two toys at a time. Place one toy slightly out of reach to encourage your baby to stretch and creep. Shake a ...

  6. Delayed sleep phase - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  7. A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

    ... phase 2 dose (RP2D) of APG-2575. Participation eligibility. Participant ... two months or doubling time in less than 6 months; enlarging adenopathy or ...

  8. Neurology - Clinical trials - Mayo Clinic

    ... two future steps: A Study of Molecular Anatomic Imaging Analysis of Tau, the Primary Pathological Protein in Progressive Supranuclear Palsy. Rochester, Minn ...

  9. Clinical trials - Oncology (Medical)

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

  10. Oncology (Medical) - Clinical trials - Mayo Clinic

    Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...